Eve Wittenberg, Senior Research Scientist at HSPH, and Lisa Prosser, Adjunct Professor and affiliated faculty member of CHDS, are collaborating with investigators at RTI Solutions and Arizona State University to measure the effects of treatment resistant schizophrenia on family members and the broader community. Schizophrenia is commonly diagnosed in late adolescence or early adulthood, and parents are often caregivers for their adult children. The life-changing effects of the illness can be immense if drug therapy is unsuccessful, as is the case in “treatment resistant” schizophrenia. Understanding the full impact of the disease on those surrounding the patient in addition to that individual him/herself is critical to valuing the benefits of successful treatment. Prosser and Wittenberg’s work employs the latest methods for valuation of health benefits to inform our understanding of the benefits of improved treatments.
- Wittenberg E, Ritter GA, Prosser LA. Evidence of Spillover of Illness Among Household Members: EQ-5D Scores from a US Sample. Medical Decision Making 2013. https://www.ncbi.nlm.nih.gov/pubmed/23100461.
- Baldwin ML. Rowman & Littlefield 2016. Beyond Schizophrenia: Living and Working with a Serious Mental Illness. https://www.amazon.com/Beyond-Schizophrenia-Working-Serious-Illness-ebook/dp/B0148Z62FE.
Related news: Eve Wittenberg Participates in Faculty Immersion Residency
Related news: CHDS and GHELI to Offer Writing Group
Related news: Opioid Epidemic Studied from an Economic Perspective